These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 19395281

  • 1. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.
    Alvarez-Muñoz P, Mauer M, Kim Y, Rich SS, Miller ME, Russell GB, Lopez-Novoa JM, Caramori ML.
    J Diabetes Complications; 2010; 24(4):242-9. PubMed ID: 19395281
    [Abstract] [Full Text] [Related]

  • 2. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M.
    Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
    [Abstract] [Full Text] [Related]

  • 3. Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients.
    Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M.
    Diabetologia; 2004 Oct; 47(10):1789-94. PubMed ID: 15502921
    [Abstract] [Full Text] [Related]

  • 4. Relationships of cell proliferation and expression of integrin subunits and type I collagen in skin fibroblasts with renal lesions in patients with IDDM.
    Jin DK, Kim Y, Mauer M, Fioretto P, Vats A, Fish AJ.
    Am J Kidney Dis; 1998 Feb; 31(2):293-300. PubMed ID: 9469500
    [Abstract] [Full Text] [Related]

  • 5. Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy.
    Gerrits T, Zandbergen M, Wolterbeek R, Bruijn JA, Baelde HJ, Scharpfenecker M.
    Int J Mol Sci; 2020 Oct 18; 21(20):. PubMed ID: 33081058
    [Abstract] [Full Text] [Related]

  • 6. Renal in situ hybridization studies of extracellular matrix related molecules in type 1 diabetes mellitus.
    Suzuki D, Yagame M, Kim Y, Sakai H, Mauer M.
    Nephron; 2002 Oct 18; 92(3):564-72. PubMed ID: 12372938
    [Abstract] [Full Text] [Related]

  • 7. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes.
    Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M.
    Diabetes; 2002 Feb 18; 51(2):506-13. PubMed ID: 11812762
    [Abstract] [Full Text] [Related]

  • 8. Endoglin Mediates Vascular Endothelial Growth Factor-A-Induced Endothelial Cell Activation by Regulating Akt Signaling.
    Bus P, Gerrits T, Heemskerk SAC, Zandbergen M, Wolterbeek R, Bruijn JA, Baelde HJ, Scharpfenecker M.
    Am J Pathol; 2018 Dec 18; 188(12):2924-2935. PubMed ID: 30248336
    [Abstract] [Full Text] [Related]

  • 9. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.
    Kidney Int; 2005 Oct 18; 68(4):1583-9. PubMed ID: 16164635
    [Abstract] [Full Text] [Related]

  • 10. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M, Takemura T, Yanagida H, Yoshioka K.
    Kidney Int; 2002 Jan 18; 61(1):113-24. PubMed ID: 11786091
    [Abstract] [Full Text] [Related]

  • 11. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
    Barbara NP, Wrana JL, Letarte M.
    J Biol Chem; 1999 Jan 08; 274(2):584-94. PubMed ID: 9872992
    [Abstract] [Full Text] [Related]

  • 12. Differential Gene Expression in Diabetic Nephropathy in Individuals With Type 1 Diabetes.
    Caramori ML, Kim Y, Goldfine AB, Moore JH, Rich SS, Mychaleckyj JC, Kirkpatrick D, Nickerson H, Krolewski AS, Mauer M.
    J Clin Endocrinol Metab; 2015 Jun 08; 100(6):E876-82. PubMed ID: 25871838
    [Abstract] [Full Text] [Related]

  • 13. Plasma endoglin in Type2 diabetic patients with nephropathy.
    Doghish AS, Bassyouni AA, Mahfouz MH, Abd El-Aziz HG, Zakaria RY.
    Diabetes Metab Syndr; 2019 Jun 08; 13(1):764-768. PubMed ID: 30641803
    [Abstract] [Full Text] [Related]

  • 14. Distribution of integrin subunits in human diabetic kidneys.
    Jin DK, Fish AJ, Wayner EA, Mauer M, Setty S, Tsilibary E, Kim Y.
    J Am Soc Nephrol; 1996 Dec 08; 7(12):2636-45. PubMed ID: 8989742
    [Abstract] [Full Text] [Related]

  • 15. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
    Høj Thomsen L, Fog-Tonnesen M, Nielsen Fink L, Norlin J, de Vinuesa AG, Krarup Hansen T, de Heer E, Ten Dijke P, Rosendahl A.
    Nephron; 2017 Dec 08; 135(4):291-306. PubMed ID: 28064277
    [Abstract] [Full Text] [Related]

  • 16. Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis.
    Diez-Marques L, Ortega-Velazquez R, Langa C, Rodriguez-Barbero A, Lopez-Novoa JM, Lamas S, Bernabeu C.
    Biochim Biophys Acta; 2002 May 21; 1587(1):36-44. PubMed ID: 12009422
    [Abstract] [Full Text] [Related]

  • 17. Endoglin negatively regulates transforming growth factor beta1-induced profibrotic responses in intestinal fibroblasts.
    Burke JP, Watson RW, Mulsow JJ, Docherty NG, Coffey JC, O'Connell PR.
    Br J Surg; 2010 Jun 21; 97(6):892-901. PubMed ID: 20473999
    [Abstract] [Full Text] [Related]

  • 18. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K, Tanabe K, Ujike H, Hinamoto N, Miyake H, Tanimura S, Sugiyama H, Sato Y, Maeshima Y, Wada J.
    PLoS One; 2018 Jun 21; 13(4):e0195779. PubMed ID: 29641565
    [Abstract] [Full Text] [Related]

  • 19. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes.
    De Cosmo S, Tassi V, Thomas S, Piras GP, Trevisan R, Cavallo Perin P, Bacci S, Zucaro L, Cisternino C, Trischitta V, Viberti GC.
    Nephron; 2002 Sep 21; 92(1):72-6. PubMed ID: 12187087
    [Abstract] [Full Text] [Related]

  • 20. Caldesmon over-expression in type 1 diabetic nephropathy.
    Millioni R, Iori E, Lenzini L, Puricelli L, Caroccia B, Arrigoni G, Rossi GP, Tessari P.
    J Diabetes Complications; 2011 Sep 21; 25(2):114-21. PubMed ID: 20801058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.